Healthcare provider profile · identity verified

Mona Parmar, M.D

Family Practice · WOODBURY, MN · NPI 1720271356

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	773	96
Gabapentin	Gabapentin	480	68
Levothyroxine Sodium	Levothyroxine Sodium	383	54
Pantoprazole Sodium	Pantoprazole Sodium	316	59
Furosemide	Furosemide	280	52
Sertraline Hcl	Sertraline Hcl	276	34
Bumetanide	Bumetanide	245	43
Metoprolol Succinate	Metoprolol Succinate	242	53
Warfarin Sodium	Warfarin Sodium	241	28
Eliquis	Apixaban	228	50
Amlodipine Besylate	Amlodipine Besylate	227	46
Tamsulosin Hcl	Tamsulosin Hcl	208	38
Duloxetine Hcl	Duloxetine Hcl	207	21
Omeprazole	Omeprazole	207	44
Potassium Chloride	Potassium Chloride	191	41
Losartan Potassium	Losartan Potassium	172	35
Lisinopril	Lisinopril	170	33
Metoprolol Tartrate	Metoprolol Tartrate	165	36
Metformin Hcl	Metformin Hcl	164	20
Mirtazapine	Mirtazapine	160	17
Jantoven	Warfarin Sodium	155	12
Simvastatin	Simvastatin	141	23
Bupropion Xl	Bupropion Hcl	139	suppressed
Famotidine	Famotidine	133	19
Clopidogrel	Clopidogrel Bisulfate	127	18
Baclofen	Baclofen	115	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	114	12
Rosuvastatin Calcium	Rosuvastatin Calcium	114	18
Donepezil Hcl	Donepezil Hcl	105	13
Citalopram Hbr	Citalopram Hydrobromide	98	17
Trazodone Hcl	Trazodone Hcl	94	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	26
Levetiracetam	Levetiracetam	87	suppressed
Allopurinol	Allopurinol	84	19
Escitalopram Oxalate	Escitalopram Oxalate	82	20
Quetiapine Fumarate	Quetiapine Fumarate	74	28
Xarelto	Rivaroxaban	69	16
Carbidopa-Levodopa	Carbidopa/Levodopa	68	14
Spironolactone	Spironolactone	65	14
Divalproex Sodium	Divalproex Sodium	64	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	suppressed
Carvedilol	Carvedilol	61	17
Midodrine Hcl	Midodrine Hcl	61	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	suppressed
Oxycodone Hcl	Oxycodone Hcl	60	20
Torsemide	Torsemide	59	16
Finasteride	Finasteride	58	suppressed
Tizanidine Hcl	Tizanidine Hcl	58	suppressed
Glipizide Er	Glipizide	56	suppressed
Metformin Hcl Er	Metformin Hcl	55	suppressed
Latanoprost	Latanoprost	54	16
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Jardiance	Empagliflozin	52	suppressed
Prednisone	Prednisone	52	13
Hydralazine Hcl	Hydralazine Hcl	50	19
Hydrochlorothiazide	Hydrochlorothiazide	50	11
Buspirone Hcl	Buspirone Hcl	49	suppressed
Methocarbamol	Methocarbamol	45	18
Aripiprazole	Aripiprazole	42	suppressed
Oxcarbazepine	Oxcarbazepine	42	suppressed
Olanzapine	Olanzapine	38	suppressed
Cephalexin	Cephalexin	36	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Tradjenta	Linagliptin	31	suppressed
Divalproex Sodium Er	Divalproex Sodium	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Digoxin	Digoxin	29	suppressed
Klor-Con M20	Potassium Chloride	29	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Atenolol	Atenolol	27	suppressed
Nystatin	Nystatin	27	18
Albuterol Sulfate Hfa	Albuterol Sulfate	25	14
Insulin Aspart Flexpen	Insulin Aspart	25	13
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Risperidone	Risperidone	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Febuxostat	Febuxostat	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Glatopa	Glatiramer Acetate	23	suppressed
Icosapent Ethyl	Icosapent Ethyl	23	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	23	23
Albuterol Sulfate	Albuterol Sulfate	22	16
Meclizine Hcl	Meclizine Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	20	20
Estradiol	Estradiol	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Prazosin Hcl	Prazosin Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Amantadine	Amantadine Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Nyamyc	Nystatin	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Bydureon Bcise	Exenatide Microspheres	14	suppressed
Haloperidol Lactate	Haloperidol Lactate	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Vancomycin Hcl	Vancomycin Hcl	13	suppressed
Gemtesa	Vibegron	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nitroglycerin	Nitroglycerin	12	11
Topiramate	Topiramate	12	suppressed
Cartia Xt	Diltiazem Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Silodosin	Silodosin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error